ACE-Inhibitor and Angiotensin II Receptor Antagonists (ARB) have a Stronger Effect on Cardiovascular Matrix Metalloproteinase Pathoway and Anti-inflammation than Ca-antagonists(Cardiovascular Pharmacology, Basic/Clinical 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)